Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance

Go back to Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) Delayed: 30.98 --0 (-0%)
Previous Close $30.98    52 Week High $31.02 
Open $3.30    52 Week Low $8.03 
Day High $30.98    P/E N/A 
Day Low $30.98    EPS $-4.38 
Volume 440,704